“…For instance, Warkentin (2004a) reorted that HIT was observed in 2.7% of patients treated with subcutaneous UFH injection, but in no patients receiving LMWH; further, thrombotic complications were more frequent in the former group (88.9%) than in the latter (17.8%). Both the bovine/procine UFH and the LMWH data were collected from medical patients receiving LMWH or UFH as "flushes", e.g., oncology patients with indwelling catheters (Mayo et al, 1990;Kadidal et al, 1999). A randomized controlled trial that compared use of porcine UFH with LMWH after hip replacement surgery found that HIT was significantly less common among patients who received the latter treatment (Lee & Warkentin, 2004;Warkentin, 2004a).…”